Please Wait
Applying Filters...

Manufacturers & Suppliers of NCGC00024890-07 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 5,607Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Ascent Innovative Medicines

02 4CHEMO

03 1CinnaGen Co

04 1Intas Pharmaceuticals

05 1Neuraxpharm

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

02

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

02

AAPS 2024
Not Confirmed
arrow

03

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

03

AAPS 2024
Not Confirmed
arrow

04

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

04

AAPS 2024
Not Confirmed
arrow

05

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 120MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

05

AAPS 2024
Not Confirmed
arrow

06

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Brand Name : Dalfyra

Dosage Form : Tablet ER.

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

06

AAPS 2024
Not Confirmed
arrow

07

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : SR Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

AAPS 2024
Not Confirmed
arrow

08

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : Extended Release Table...

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

08

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Dalfampridine

Dosage : Extended Release Table...

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Spain

blank